NEW YORK, July 17, 2017 (GLOBE NEWSWIRE) -- The Klein Law Firm announces that a class action complaint has been
filed on behalf of shareholders of Roche Holding AG (OTCMKTS:RHHBY) who purchased shares between March 2,
2017 and June 5, 2017. The action, which was filed in the United States District Court for the
District of New Jersey, alleges that the Company violated federal securities laws.
In particular, the complaint alleges that throughout the Class Period, defendants made materially false and/or
misleading statements and/or failed to disclose that (1) the combination of Perjeta and Herceptin is only marginally more effective
than Herceptin alone in preventing breast cancer; and (2) as a result, Defendants' statements about Roche Holding AG's business,
operations and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.
Shareholders have until August 7, 2017 to petition the court for lead plaintiff status. Your
ability to share in any recovery does not require that you serve as lead plaintiff. You may choose to be an absent class
member.
If you suffered a loss during the class period and wish to obtain additional information, please contact Joseph
Klein, Esq. by telephone at 212-616-4899 or visit http://www.kleinstocklaw.com/pslra-sa/roche-holding-ag?wire=3.
Joseph Klein, Esq. is an experienced attorney and has also practiced as a Certified Public Accountant. Mr. Klein
represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney
advertising. Prior results do not guarantee similar outcomes.
CONTACT: Joseph Klein, Esq. Empire State Building 350 Fifth Avenue 59th Floor New York, NY 10118 Telephone: (212) 616-4899 Fax: (347) 558-9665 www.kleinstocklaw.com
